Jonathan Achter (Copenhagen / DK), Estefania Torres Vega (Copenhagen / DK), Andrea Sorrentino (Copenhagen / DK), Konstantin Kahnert (Copenhagen / DK), Katrine Douglas Galsgaard (Copenhagen / DK), Pablo Hernandez-Veras (Copenhagen / DK), Michael Wierer (Copenhagen / DK), Jens Juul Holst (Copenhagen / DK), Jørgen Wojtaszewski (Copenhagen / DK), Robert William Mills (Copenhagen / DK), Rasmus Kjøbsted (Copenhagen / DK), Alicia Lundby (Copenhagen / DK)
Background: Insulin signaling regulates cardiac substrate utilization and is implicated in physiological adaptations of the heart. Alterations in the signaling response within the heart are believed to contribute to pathological conditions such as type-2 diabetes and heart failure. While extensively investigated in several metabolic organs using phosphoproteomic strategies, the signaling response elicited in cardiac tissue in general, and specifically in the specialized cardiomyocyte cells, has not yet been investigated to the same extent.
Methods: Insulin or vehicle was administered to male C57BL6/JRj mice, and ventricular tissue was analyzed by quantitative phosphoproteomics to evaluate the insulin signaling response. Cardiomyocytes from a cardiac and skeletal muscle-specific Tbc1d4 knockout mouse and wildtype littermates were used to study Tbc1d4"s role in insulin signal transduction. Phosphoproteomic studies involved isobaric peptide labeling with Tandem Mass Tags (TMT), enrichment for phosphorylated peptides, fractionation via micro-flow reverse-phase liquid chromatography, and high-resolution mass spectrometry measurement.
Results: We quantified 10,399 phosphorylated peptides from ventricular tissue and 12,739 from isolated cardiomyocytes, localizing to 3,232 and 3,128 unique proteins, respectively. In cardiac tissue, we identified 84 insulin-regulated phosphorylation events, including sites on the Insulin Receptor (Insr;Y1351, Y1175, Y1179, Y1180) itself as well as the Insulin receptor substrate protein 1 (Irs1;S522, S526). Predicted kinases with increased activity in response to insulin stimulation included Rps6kb1, Akt1 and Mtor. Tbc1d4 emerged as a major phosphorylation target in cardiomyocytes. Despite limited impact on the global phosphorylation landscape, Tbc1d4 deficiency in cardiomyocytes attenuated insulin-induced Glut4 translocation and induced protein remodeling. We observed 15 proteins significantly regulated upon knockout of Tbc1d4. While Glut4 exhibited decreased protein abundances consequent to Tbc1d4-deficiency, Txnip levels were notably increased. Stimulation of wildtype cardiomyocytes with insulin led to the upregulation of 262 significant phosphorylation events, predicted to be regulated by kinases such as Akt1, Mtor, Akt2, and Insr. In cardiomyocytes, the canonical insulin signaling response is elicited in addition to regulation on specialized cardiomyocyte proteins, such as Kcnj11;Y12 and Dsp;S2597. Details of all phosphorylation sites are provided.